Wird diese Nachricht nicht richtig dargestellt, klicken Sie bitte hier.
Deutsche Sarkom Stiftung
• SPAGN Member groups • Unsubscribe newsletter • Contact
Dear SPAGN Members and Friends,

We are excited to share several incredible opportunities awaiting you in 2025! From our first-ever conference in the United States to new awards recognizing outstanding advocacy efforts and participation in major international events, this year is set to be unforgettable.

Read on to discover how you can get involved, seize these unique opportunities, and continue driving impactful change within the sarcoma community.

All the best from the
SPAGN Board of Directors & Team
SPAGN Annual Conference 2025
Registration for our SPAGN Annual Conference has been already open. If you have missed the announcement, don't forget to register now and seize the opportunity to be part of our first-ever SPAGN Annual Conference in the United States, co-hosted by the National Cancer Institute!  
 
What's new!?  
 
📋 Preliminary Agenda: The preliminary agenda is now live on the event page! Check out the exciting sessions planned for this year and start organizing your trip.
 
✈️ Travel Grants: A limited number of travel grants are available to assist with travel and accommodation for SPAGN members only. 
 
Don’t miss the chance to join & use the opportunity to learn, engage and connect with experts and fellow advocates on this year’s impactful event— secure your spot today!
🏆 Submit your Application

Continuing the tradition, SPAGN will once again honor the outstanding efforts of its member organizations in advancing patient support, education, and advocacy through the Advocacy in Action Award.

This year, we have introduced an additional  prize - the Paola Gonzato Memory  Award! Sponsored by the Fondazione Paola  Gonzato Rete Sarcoma ETS, which  focuses  on projects dedicated to improving the lives of those affected by bone sarcomas.

📅 Deadline for both awards: February 28, 2025

📍 The Awards will be presented at: The SPAGN Annual Conference 2025
✍️ Check Out Our New Blog

The story behind the Sarcoma of the Year 2024: Dedifferentiated Liposarcoma

Dedifferentiated liposarcoma remains a major challenge for researchers and clinicians striving to improve outcomes. Despite setbacks like the Brightline trial, which highlighted the complexity of treatment evaluation, efforts continue to advance targeted therapies and identify personalized approaches for better patient care.
🏆 Submit your Application
ESMO Sarcoma & Rare Cancers congress
📅Save the date: March 20-22, 2025
📍Location: Lugano, Switzerland

We are thrilled to share that once again SPAGN will be represented with a booth at the conference. Furthermore, we are delighted to extend a special opportunity to our SPAGN members by offering 15 free registrations for the upcoming meeting.

Act now to seize this opportunity and secure your spot by emailing us the following details at info@sarcoma-patients.org.

Full Name 
Organisation's Name 
Full Address 
ESMO ID (member number), if known. 

The first 15 registrants will receive free entry to the congress.

Don't hesitate – claim your spot today!
Follow us on our Whatsapp Channel! Join here!
X handle Facebook Company Name Instagram Profile YouTube channel LinkedIn company page
Sarcoma Patient Advocacy Global Network e.V./Assoc., 
Untergasse 36,
61200 Wölfersheim/Germany
Wenn Sie diese E-Mail (an: unknown@noemail.com) nicht mehr empfangen möchten, können Sie diese hier kostenlos abbestellen.